Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 36462046.
- Also identified by DOI 10.1007/s00330-022-09307-z.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC). The ECV fraction before NCRT (ECV<sub>pre)</sub> and/or ECV after NCRT (ECV<sub>post</sub>) of rectal tumors was assessed, and ECV<sub>Δ</sub> was calculated as ECV<sub>post</sub> - ECV<sub>pre</sub>. The histopathologic tumor regression grading (TRG) was assessed. pCR (TRG 0 grade) was defined as the absence of viable tumor cells in the primary tumor and lymph nodes. Demographic and clinicopathological characteristics and ECV fraction were compared between the pCR and non-pCR groups. A mixed model was constructed by logistic regression. The performance for predicting pCR was assessed with the area under the receiver-operator curve (AUC). The AUCs of the different methods were compared by the method proposed by DeLong et al. RESULTS: Seventy-five patients were included; 17 achieved pCR, and 58 achieved non-pCR. The ECV<sub>post</sub> (17.05 ± 2.36% vs. 29.94 ± 1.20%; p < 0.001) and ECV<sub>Δ</sub> (- 17.01 ± 3.01% vs. 0.44 ± 1.45%; p < 0.001) values in the pCR group were significantly lower than those in the non-pCR group. The mixed model that combined ECV<sub>post</sub> with ECV<sub>Δ</sub> achieved an AUC of 0.92 (95% confidence interval (CI) = 0.81-0.98), which was higher than that of ECV<sub>post</sub> (AUC, 0.91 (95% CI = 0.80-0.97); p = 0.60) or ECV<sub>Δ</sub> (AUC, 0.90 (95% CI = 0.79-0.97); p = 0.61). ECV<sub>post</sub> and ECV<sub>Δ</sub> determined by using equilibrium contrast-enhanced CT were useful in distinguishing between pCR and non-pCR patients with LARC who received NCRT. • ECV<sub>post</sub> and ECV<sub>Δ</sub> (ECV<sub>post</sub> - ECV<sub>pre</sub>) differed significantly between the non-pCR and pCR groups. • ECV<sub>pre</sub> cannot be used to predict the efficacy of neoadjuvant chemoradiotherapy. • ECV<sub>post</sub> combined with ECV<sub>Δ</sub> had the best performance with an AUC of 0.92 for predicting pCR after NCRT in LARC.
Medical subject headings
- Rectal Neoplasms
- Neoplasms, Second Primary